DexCom, Inc.
US ˙ NasdaqGS ˙ US2521311074

SecurityDXCM / DexCom, Inc.
InstitutionWELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2
Latest Disclosed Ownership308 shares
Latest Disclosed Value $ 26,885
WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 reports 4.05% decrease in ownership of DXCM / DexCom, Inc.

On August 26, 2025 - WELLS FARGO VARIABLE TRUST - Wells Fargo VT Index Asset Allocation Fund Class 2 filed a NPORT-P form disclosing ownership of 308 shares of DexCom, Inc. (US:DXCM) valued at $26,885 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 321 shares of DexCom, Inc.. This represents a change in shares of -4.05% during the quarter. The current value of the position is $22,441 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Dexcom EC US2521311074 308 -13 -4.05 27 23.81 0.0396
2025-05-27 2025-03-31 NP Dexcom EC US2521311074 321 -10 -3.02 22 -16.00 0.0330
2025-02-26 2024-12-31 NP Dexcom EC US2521311074 331 -31 -8.56 26 4.17 0.0368
2024-11-25 2024-09-30 NP Dexcom EC US2521311074 362 -7 -1.90 24 -41.46 0.0335
2024-08-26 2024-06-30 NP Dexcom EC US2521311074 369 3 0.82 42 -18.00 0.0599
2024-05-28 2024-03-31 NP Dexcom EC US2521311074 366 -21 -5.43 51 4.17 0.0728
2024-02-28 2023-12-31 NP Dexcom EC US2521311074 387 -11 -2.76 48 29.73 0.0720
2023-11-22 2023-09-30 NP Dexcom EC US2521311074 398 -45 -10.16 37 -33.93 0.0597
2023-08-28 2023-06-30 NP Dexcom EC US2521311074 443 4 0.91 57 9.80 0.0859
2023-05-25 2023-03-31 NP Dexcom EC US2521311074 439 -9 -2.01 51 2.00 0.0791
2023-02-24 2022-12-31 NP Dexcom EC US2521311074 448 -16 -3.45 51 35.14 0.0811
2022-11-29 2022-09-30 NP DEXCOM INC USD.001 EC US2521311074 464 -11 -2.32 37 5.71 0.0610
2022-08-29 2022-06-30 NP DEXCOM INC USD.001 EC US2521311074 475 356 299.16 35 -41.67 0.0539
2022-05-31 2022-03-31 NP DEXCOM INC USD.001 EC US2521311074 119 -4 -3.25 61 -9.09 0.0797
2022-02-28 2021-12-31 NP DEXCOM INC USD.001 EC US2521311074 123 -4 -3.15 66 -4.35 0.0794
2021-11-24 2021-09-30 NP DEXCOM INC USD.001 EC US2521311074 127 -5 -3.79 69 23.21 0.0863
2021-08-27 2021-06-30 NP DEXCOM INC USD.001 EC US2521311074 132 -7 -5.04 56 14.29 0.0688
2021-06-01 2021-03-31 NP DEXCOM INC USD.001 EC US2521311074 139 -7 -4.79 50 -7.55 0.0630
2021-03-01 2020-12-31 NP DEXCOM INC USD.001 EC US2521311074 146 -9 -5.81 54 -15.87 0.0685
2020-11-25 2020-09-30 NP DEXCOM INC USD.001 EC US2521311074 155 -1 -0.64 64 0.00 0.0857
2020-08-28 2020-06-30 NP DEXCOM INC USD.001 EC US2521311074 156 156 63 0.0888
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.